News

A group of ten patients applied a 10% alpha-hydroxy acid (AHA) cream each evening for two weeks prior to in-office procedures. This conditioning phase served to acclimate the

The study has involved 342 patients with complex, hard-to-heal diabetic foot ulcers with 90% of therapy days occurring in the home care setting. In the study, for patients

Judd Hoffman, president and CEO of AMT, said: “Using AMT’s proven global sales experience and extensive global distributor network as our foundation, we intend to increase SheerVision’s Firefly

Vertex intends to grant the underwriters an over-allotment option to purchase up to an additional 900,000 shares of its common stock. Concurrently with the offering of its common

This transaction, including a new four-year supply agreement with DePuy, enhances Greatbatch’s and Precimed’s strategic relationship with one of the largest orthopedic companies in the world. The addition

This decision comes after its recent acquisition of Intertech Bio which has propelled the company into the multi-billion dollar biotechnology industry through the addition of significant partnerships and

Under the terms of the agreement, Sigma-Tau will oversee all necessary regulatory filings, and will be responsible for all marketing and sales of Zingo in their territory. The

Under the terms of the agreement, Merck will provide up-front and research support funding to the CACS as well as milestone and royalty payments upon market approval. The

Watson is seeking marketing approval of silodosin from the FDA for the treatment of the signs and symptoms associated with benign prostatic hyperplasia (BPH), or enlarged prostate. Watson